https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-updated-drug-labeling-fludarabine-phosphate-under-project-renewal
FDA approves updated drug labeling for fludarabine phosphate under Project Renewal | FDA
On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an...
drug labelingfludarabine phosphatefdaapprovesupdated
https://www.cancer.gov/about-cancer/treatment/drugs/fludarabinephosphate
Fludarabine Phosphate - NCI
This page contains brief information about fludarabine phosphate and a collection of links to more information about the use of this drug, research results,...
fludarabine phosphatenci
https://www.mayo.edu/research/clinical-trials/cls-20309975
Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in...
Learn more about services at Mayo Clinic.
cytarabine daunorubicinfludarabine phosphateliposomalcpx351
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-01659
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin...
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients with Newly Diagnosed Acute Myeloid...
fludarabine phosphatefilgrastim sndzgemtuzumab ozogamicincytarabineidarubicin